mFOLFOX6 therapy could control ascites caused by peritonitis carcinomatosis in a patient with recurrent colorectal cancer. A case report-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

mFOLFOX6 therapy could control ascites caused by peritonitis carcinomatosis in a patient with recurrent colorectal cancer. A case report

Published:2008 Issue:2 Volume:3 Page:316-320
ISSN:1880-5302
Container-title:Palliative Care Research
language:
Short-container-title:Palliat Care Res

Author:

Sugimoto Masakazu,Matsui Masateru,Harada Masanori,Yamauchi Yumiko,Moriyama Nao,Ando Kanae,Yamamoto Makoto,Yamaoka Hisayo,Ono Chiemi,Hayama Tamuro,Matsuda Keiji,Watanabe Toshiaki,Eguchi Kenji,Yamaoka Keiko

Publisher

Japanese Society for Palliative Medicine

Subject

General Medicine

Reference8 articles.

1. 2)Grothey A, Sargent D, Goldberg RM, et al. Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment. J Clin Oncol 2004; 22: 1209-1214.

2. 3) 大腸癌研究会編. 大腸癌治療ガイドライン-医師用2005年版. p.30-33,金原出版, 東京, 2005.

3. 4)Goldberg RM, Sargent DJ, Morton RF, et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 2004; 22: 23-30.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP